Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reversal of multidrug resistance in hematological malignancies.

Blood reviews - 1 Jun 1999

Vossebeld P J, Sonneveld P

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP Binding Cassette Transporter, Subfamily B, Member 1
Share to Drug Resistance, Multiple
Share to Drug Resistance, Neoplasm
Share to Leukemia, Myeloid

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lymphoma, Non-Hodgkin

Share to Multiple Myeloma

Share to Phenotype

Share to Protein Structure, Secondary

Source

Identifiers

PMID: 10414943
DOI: 10.1016/s0268-960x(99)90013-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reversal of multidrug resistance in hematological malignancies.PMID 10414943Read ↗

Drug Resistance in Hematological MalignanciesSemantic proximity Read ↗

Multidrug resistance in hematological malignancy.Semantic proximity Read ↗

Mechanisms of Multidrug Resistance in Cancer ChemotherapySemantic proximity Read ↗

Multidrug resistance: molecular mechanisms and clinical relevanceSemantic proximity Read ↗

Multidrug resistance in myeloma: seeing the whole picture.Semantic proximity Read ↗

Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancerSemantic proximity Read ↗

Revisiting the ABCs of Multidrug Resistance in Cancer ChemotherapySemantic proximity Read ↗

Multidrug Resistance: Are We Still Afraid of the Big Bad WolfSemantic proximity Read ↗

Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy.Semantic proximity Read ↗

Mechanisms and strategies to overcome multiple drug resistance in cancerSemantic proximity Read ↗

Drug resistance in hematologic malignanciesSemantic proximity Read ↗

How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.